BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

WIL Research Laboratories, LLC Appoints David Spaight as Chief Executive Officer


5/17/2010 6:34:48 AM

FAIRFIELD, N.J.--(BUSINESS WIRE)--WIL Research Laboratories, a privately held global Contract Research Organization (CRO) and leading provider of drug development and chemical and food safety services, announced the appointment of David Spaight to the position of Chief Executive Officer and named him to their Board of Directors. Mr. Spaight will oversee the Company’s four major businesses – WIL Research Laboratories, NOTOX, Midwest BioResearch and QS Pharma – and will continue to implement a long-term strategy of integrating the businesses to provide greater value and full service to their clients, across the globe.

Mr. Spaight brings more than 25 years of experience in the life and analytical sciences industry. He has extensive experience in business integration, operational improvement and client relationship development. Most recently, he served as President of MDS Pharma Services, a leading provider of innovative drug discovery and development solutions to the pharmaceutical and biotechnology industries. He managed a team of more than 3,500 professional across 35 sites in 27 countries. During his tenure at MDS, he served on the Board of Directors for the Association of Clinical Research Organizations (ACRO) and was named Chairman for 2008. Previously, Mr. Spaight served as Senior Vice President at Fisher Scientific Products, where he was responsible for the integration of the sales, marketing and research and development teams in North America, Europe and Asia. Prior to joining Fisher, Mr. Spaight spent 20 years with PerkinElmer Life and Analytical Sciences, rising through several management roles to the position of Vice President of Global Sales and Marketing. He received his Bachelor of Science degree in Chemistry and a Masters of Business Administration degree, both from the University of Michigan.

“Pharma companies around the world are looking for specific expertise in key areas of drug discovery and development,” said Mr. Spaight. “The scientific expertise of our staff is unmatched and provides a strong base for future growth. I look forward to strengthening this organization as we continue to deliver exceptional value to our clients.”

MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6292697

Contact:

For WIL Research Laboratories Ken Li, 312-532-4675

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES